The Transcript of The Joint Corp.'s (JYNT) Second Quarter Earnings Discussion for the Year 2025
The Joint Corp., a leading provider of chiropractic services, held its Q2 2025 Earnings Conference Call on August 7, 2025. During the call, CEO Sanjiv Razdan and CFO Scott Bowman discussed the company's financial results and strategic shifts.
The Q2 2025 earnings call took place at 5:00 PM ET. David Barnard, representing Alliance Advisors Investor Relations, and Jeremy Scott Hamblin from Craig-Hallum Capital Group LLC, Research Division, among others, participated in the conference call. A slide presentation, which can be found at ir.thejoint.com under Events, was used for the call.
The Joint Corp reported Q2 2025 financial results with a 5% revenue growth to $13.3 million, system-wide sales up by 2.6% to $129.6 million, and consolidated net income of $93,000. This significant improvement is in contrast to a $3.6 million loss in Q2 2024. Adjusted EBITDA increased 52% to $3.2 million, reflecting improved profitability.
The company also refranchised 37 clinics for $11.2 million and acquired Northwest regional developer territory rights for $2.8 million. This move strategically positions The Joint Corp towards a pure-play franchisor model, with franchised clinics now representing 92% of its portfolio and a total clinic count of 967.
Due to softer sales trends, The Joint Corp revised its 2025 guidance, now expecting system-wide sales between $530 million and $550 million and low single-digit comparable sales growth. The company reported a net loss from continuing operations of $990,000, better than the $1.7 million loss in Q2 2024, and improved adjusted EBITDA from continuing operations to $88,000 from a prior loss of $380,000.
Additionally, The Joint Corp announced plans to restate its full-year 2024 and Q1 2025 financials due to accounting errors related to impairment charges on clinics held for sale. This restatement will reduce the 2024 net loss by $2.2 million and increase Q1 2025 net income by $0.5 million. However, this restatement will not impact adjusted EBITDA or cash positions but will result in reporting a material weakness in internal controls over financial reporting.
The company maintained a strong liquidity position with $29.8 million in unrestricted cash and a $20 million credit line.
The press release about the quarter ended June 30, 2025, has been issued by The Joint Corporation. It can be found on the Investor Relations section of The Joint Corporation's website. The safe harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to all statements other than statements of historical facts. Actual results may differ materially from expectations or assumptions.
Key themes from the call highlighted the progress in refranchising, enhancing profitability, and the transition to a franchisor-focused business model amid a challenging sales environment.
[1] The Joint Corp (NASDAQ: JYNT) Press Release, August 7, 2025, ir.thejoint.com [2] The Joint Corp (NASDAQ: JYNT) Q2 2025 Earnings Conference Call Transcript, August 7, 2025, seekingalpha.com [3] The Joint Corp (NASDAQ: JYNT) Q2 2025 Earnings Results, August 7, 2025, yahoo.com [4] The Joint Corp (NASDAQ: JYNT) Q2 2025 Earnings Conference Call Presentation, August 7, 2025, ir.thejoint.com [5] The Joint Corp (NASDAQ: JYNT) Q2 2025 Earnings Conference Call, August 7, 2025, investorcalendar.com
Business strategically shifted as The Joint Corp, a chiropractic services provider, refranchised 37 clinics and acquired Northwest regional developer territory rights, moving towards a pure-play franchisor model. This change in business model, coupled with investing in improvements and financial results, were discussed during the Q2 2025 Earnings Conference Call. Finance-wise, the company reported increased revenue, system-wide sales, net income, and Adjusted EBITDA compared to Q2 2024.
%20Second%20Quarter%20Earnings%20Discussion%20for%20the%20Year%202025){kind=link}